Miki Kapoor is President and Chief Executive Officer of Verana Health. With two decades of diverse experience exclusively in healthcare – in operations, finance, strategy and policy – Miki has a notably broad perspective on the U.S. healthcare system. Prior to joining Verana, Miki was CEO of Tea Leaves Health, a SaaS healthcare data company he scaled over the course of three years (acquired by Welltok). He was previously the President of Everyday Health, a publicly traded company he directed toward utilizing large-scale data for effective patient-physician communication. Miki also served as Head of the Global Payer and Provider Division for IMS Health, Executive Vice President of Health Systems for the Clinton Foundation, and has in-depth experience advising healthcare executives for ten years at McKinsey & Company and on Wall Street.
Miki holds an MBA and MPH from Yale University and a Bachelor’s degree in Biology from Washington University in St. Louis. He is a Fulbright Fellow, formerly a visiting professor at two universities, and sits on the boards of several healthcare organizations.
Miki Kapoor on LinkedIn
With the creation of these comprehensive clinical databases, we can learn from the real experiences of millions of patients. This is an opportunity to drive meaningful change in patient lives with data analytics like I've never seen before.
Marie-Eve Piche, Verana’s Chief Financial Officer, has nearly two decades of financial management experience in public and fast-growing private companies. Marie-Eve was previously the CFO of Pymetrics and built the financial strategy and capabilities that enabled a successful Series B fundraising. She also served as Vice President of Financial Planning and Analysis at AppNexus, where she helped grow revenue by more than six times during her tenure and was on the team that drove the $1.6B acquisition by AT&T. She began her career at General Electric, holding key financial roles at NBC Sports and Telemundo.
Marie-Eve received her dual MBA from Columbia University and London Business School. She also holds a Master’s in economics from McGill University and a B.Com. from H.E.C. Montreal.Marie-Eve Piche on LinkedIn
Verana Health is a company that is doing ground-breaking work with technology and data, and is being built by a team that works tirelessly to deliver against its commitment to patients. I'm thrilled to contribute to the impact I know this company will make.
Ellenmarie Rhone is Senior Vice President of People & Culture at Verana Health, where she is responsible for leading all human capital efforts. Her focus is on sourcing and developing talent and executing strategic programs that support culture and engagement. Ellenmarie is a seasoned human resources leader with substantial experience building high-performing teams and operating systems for high growth technology companies. She was most recently Vice President of Talent and Training for ReacHIRE, a venture-funded startup that works with experienced, executive-level women returning to the workforce after a career break. Ellenmarie previously served as Vice President of Human Resources for FirstBest.
Ellenmarie earned her MBA from Simmons School of Management, and her Bachelor’s in Education from Bridgewater State University.Ellenmarie Rhone on LinkedIn
As the mom of a child with a chronic disease I have experienced how new treatments change lives. I’m excited to be a part of building a team at Verana that will help drive that change.
Marc Berger is Senior Vice President and General Counsel at Verana Health, where he is responsible for all of the company’s legal functions, including corporate, privacy, commercial contracting, health law, and intellectual property activities. Marc was previously General Counsel at Flatiron Health, where he was a member of the four-person team that negotiated the $2.1B acquisition by Roche. Prior to Flatiron, Marc was Vice President and Assistant General Counsel at Medidata Solutions, where he had global responsibility for negotiating agreements with life science companies and partners for Medidata’s clinical trial technology and service offerings.
Marc received his JD and MBA from the University of Miami School of Law, and his BS in Management and International Business from Penn State University.Marc Berger on LinkedIn
I love working at mission-driven companies. Verana’s deep commitment to improving patient care and accelerating scientific research with clinical data is something the entire organization is behind.
Nitin Karandikar leads the Technology and Data team, which is responsible for development of the data technology platform, data science algorithms and AI models at Verana Health. Our secure cloud-based platform and advanced algorithms enable Verana to implement cutting-edge real-world evidence (RWE) studies and subscription data products based on clinical health data. Nitin has over 25 years of technical and management experience in software development. Before Verana, he held senior technical leadership positions at a number of health technology companies, including DeVero and Intuit Health. Prior to that, he was VP of Engineering at Epocrates, an early pioneer in building mobile health technology apps at the point of care.
Nitin has an M.S. in Computer Engineering from the University of California at Santa Barbara.Nitin Karandikar on LinkedIn
We get to provide key insights on clinical questions using the latest technologies in data science and AI. Verana has an amazing team working on challenging problems and it’s a privilege to be a part of this journey.
Chet Kumar is Vice President of Life Science, Commercial for Verana Health, working with medical device and pharmaceutical companies, physicians, and other healthcare stakeholders to bring together medical knowledge and data science to accelerate innovation. Before joining Verana, Chet held numerous marketing and sales VP positions at DigiSight and VisionCare Ophthalmic Technologies working with enterprise health systems, physician practices, and payers. At VisionCare, he advanced clinical development and commercialization of the first-ever implantable medical device for age-related macular degeneration, including gaining novel CPT coding from the AMA and Medicare coverage across all regional contractors after FDA approval. Chet previously held positions at Oculex Pharmaceuticals (acquired by Allergan) and Incyte Pharmaceuticals.
Chet earned his Doctor of Physical Therapy from the University of Southern California and a Bachelor’s degree in Psychology from the University of California at San Diego.Chet Kumar, DPT on LinkedIn
It's rewarding to work with physicians and life science teams to leverage medical knowledge and data science in order to get the best treatments to patients in more insightful and efficient ways.
Don Butler brings several decades of sales and business leadership experience to Verana Health, where he serves as Vice President of Life Science, Commercial. Don joins Verana from Outcome Health, where he served as Senior Vice President of Clinical Research Solutions. Prior to Outcome Health, Don was Senior Vice President of Global Enterprise Sales at Medidata Solutions, where he led the global sales team responsible for selling clinical and data analytics solutions that support over half of the world’s clinical trials. He previously held sales leadership roles for Oracle Health Sciences and Siebel Life Sciences.
Don holds a Bachelor’s degree in business from Ithaca College and is an alumnus of Harvard Business School’s extensive executive education program.Don Butler on LinkedIn
My career is inspired by the clinical trial that saved my mother’s life from stage 4 ovarian cancer. Verana gives me the opportunity to help connect patients with clinical trials that can improve and save their lives.
Hylton Kalvaria is Vice President of Strategic Partnerships, leading Verana’s major partnership initiatives with medical associations, life science companies, and regulatory bodies. Hylton joins Verana from Flatiron Health, where he founded, built and led the West Coast business, representing half of Flatiron’s commercial activity. In that capacity, Hylton’s team led the design and execution of Flatiron’s first regulatory-grade projects intended for influential stakeholder audiences, including the FDA. Hylton previously held a variety of roles at Genentech and was appointed to lead a CEO-sponsored initiative focused on identifying emerging sources of real world data and utilizing those data across the Genentech organization, an initiative that led to Roche’s initial investment in Flatiron.
Hylton holds an MBA and BS in Economics from Duke University.Hylton Kalvaria on LinkedIn
I'm excited to make a big impact on how we generate evidence for new and existing drugs and devices. We have an opportunity to reinvent that process to be more patient and provider focused.
Karim Damji serves as Head of Product at Verana Health, where he is responsible for leading product strategy and development. Karim, a product veteran with a 20-year track record of success, has launched some of the most notable solutions in healthcare and technology. He most recently led product, technology and marketing at Saama, where he launched solutions for the life science industry including the award-winning Life Science Analytics Cloud. Prior to Saama, Damji led software strategy and product at Plantronics. He also served in leadership positions spanning business development, product management, sales, and network engineering at Cisco, and as founding head of product at Vocera Communications, MobileIron and DiVitas.
Damji earned his Bachelor’s degree in computational and applied mathematics from San Jose State University.Karim Damji on LinkedIn
At Verana, I’ve found a team that I believe is going to revolutionize healthcare with data. It is refreshing and deeply gratifying to work with people who are so purpose-driven.
Ronald Cantrell leads clinical data science at Verana as Senior Director and Principal Data Scientist. Prior to Verana, Ron was Principal Data Scientist at Genentech and led real world evidence generation across the Ophthalmology portfolio. In this role, he worked with product development and medical affairs teams to apply scientific expertise to real world data, creating insights to enable better development decisions for treatments that could improve patient care. Ron was previously a methodologist in Eli Lilly’s Global Health Outcomes division, covering diabetes, immunology and neuroscience.
Ron holds a PhD in Epidemiology and an MPH in International Health from the University of Alabama at Birmingham, and a Bachelor’s degree in Natural Sciences from Johns Hopkins University.Ronald Cantrell, PHD on LinkedIn
I joined Verana to be a part of the unique and high impact opportunity to answer some of the most pressing questions in medicine by applying scientific expertise to the world's largest clinical specialty database.
Ritu Tandon is Director of Marketing at Verana Health and leads all marketing and strategic communication initiatives. She has dedicated her career to scaling innovation and expanding access within health care and education, and has experience leading all aspects of new product launch. Prior to Verana, Ritu served as the first Program Director for the 49ers STEM Leadership Institute, where she also spearheaded the team that launched the Learning Innovation Hub, a program that connects education technology entrepreneurs with Silicon Valley educators. Ritu was selected as a New Sector Alliance Americorps Fellow and an Education Pioneers Fellow.
Ritu earned her Bachelor’s degree in Biology from MIT and holds an MA in Education Policy, Organization, and Leadership Studies from Stanford.Ritu Tandon on LinkedIn
Research drives medical innovation and decision-making. At Verana, I get to be part of a team that will help patients access the best care possible more quickly than ever before by reimagining how medical research happens with real-world data.
Kleiner, Perkins, Caufield & Byers
Chief Executive Officer,
American Academy of Neurology
Chief Executive Officer,
American Academy of Ophthalmology
Co-Founder and Managing Director,
Biomatics Capital Partners
Managing Director, Healthcare,
Verana Health and Lagunita Biosciences
Chief Executive Officer,
Ahmanson Professor in Ophthalmology,,
Stein Eye Institute, UCLA
Verana Health is backed by leading institutional investors and industry veterans:
Brook Byers, founding member and senior partner of Kleiner, Perkins, Caufield, and Byers.